P2RY12 and ischemic stroke: P2Y12 receptor inhibitors, such as clopidogrel and ticagrelor, are clinically used for the secondary prevention of ischemic stroke due to their ability to reduce P2Y12-mediated platelet aggregation and provide neuroprotective effects [43,44].